Abstract
Objective
The aim of this study is to investigate the relationship between the presence of aortic valve sclerosis (AVS) and aggregate index of systemic inflammation (AISI), in patients with hypertension (HT).
Material and Methods
Patients with HT diagnosis of 10 years or more who applied to the cardiology outpatient clinic between January and June 2024 were included in our study. Patients were divided into two groups as AVS detected (84 patients) and non-AVS detected (293 patients). AISI was calculated with the neutrophil x platelet x monocyte / lymphocyte formula.
Results
AISI was found to be statistically higher in the AVS detected group [421 (127-3400) and 141.57 (21-2332); p<0.001]. Apart from AISI, age, diabetes history, left ventricular wall thickness and mitral valve early diastolic wave were found to be different between the two groups. In multivariate regression analysis, age (p<0.001), left ventricular posterior wall diameter (p=0.012) and AISI (p<0.002) were found to be independent predictors of AVS development.
Conclusion
We found that AISI can be used to detect AVS in long-term HT patients. High AISI values in HT patients can be used as an early warning parameter for poor prognosis.
Keywords: Aortic valve sclerosis, hypertension, aggregate index of systemic inflammation
References
Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341(3):142-147.
Lindroos M, Kupari M, Valvanne J, Strandberg T, Heikkilä J, Tilvis R. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J. 1994;15(7):865-870.
Chandra HR, Goldstein JA, Choudhary N, O’Neill CS, George PB, Gangasani SR, et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J Am Coll Cardiol. 2004;43(2):169-175.
Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of “degenerative” valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90(2):844-853.
Zinellu A, Collu C, Nasser M, Paliogiannis P, Mellino S, Zinellu E, et al. The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis. J Clin Med. 2021;10(18):4134.
Gharacholou SM, Karon BL, Shub C, Pellikka PA. Aortic valve sclerosis and clinical outcomes: moving toward a definition. Am J Med. 2011;124(2):10310.
Cuniberti LA, Stutzbach PG, Guevara E, Yannarelli GG, Laguens RP, Favaloro RR. Development of mild aortic valve stenosis in a rabbit model of hypertension. J Am Coll Cardiol. 2006;47(11):2303-2309.
Basile C, Fucile I, Lembo M, Manzi MV, Ilardi F, Franzone A, et al. Arterial hypertension in aortic valve stenosis: a critical update. J Clin Med. 2021;10(23):5553.
Paliogiannis P, Ginesu GC, Tanda C, Feo CF, Fancellu A, Fois AG, et al. Inflammatory cell indexes as preoperative predictors of hospital stay in open elective thoracic surgery. ANZ J Surg. 2018;88(6):616-620.
Pinna A, Porcu T, D’Amico-Ricci G, Dore S, Boscia F, Paliogiannis P, et al. Complete blood cell count-derived ınflammation biomarkers in men with age-related macular degeneration. Ocul Immunol Inflamm. 2019;27(6):932-936.
Madhur MS, Elijovich F, Alexander MR, Pitzer A, Ishimwe J, Van Beusecum JP, et al. Hypertension: do ınflammation and ımmunity hold the key to solving this epidemic? Circ Res. 2021;128(7):908-933.
Jin N, Huang L, Hong J, Zhao X, Hu J, Wang S, et al. The association between systemic inflammation markers and the prevalence of hypertension. BMC Cardiovasc Disord. 2023;23(1):615.
Xiu J, Lin X, Chen Q, Yu P, Lu J, Yang Y, et al. The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension. Front Cardiovasc Med. 2023;10:1163900.
Mantovani A, Pernigo M, Bergamini C, Bonapace S, Lipari P, Valbusa F, et al. Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. Metabolism. 2015;64(8):879-887.
